Summary Safety Review - Atypical antipsychotics - Assessing the potential risk of sleep walking and sleep-related eating disorder

Health Canada reviewed the potential risk of SW and SRED with the use of atypical antipsychotics, following the publication of a case report describing these events in a patient treated with ziprasidone. Sleep walking is a sleep disorder that causes people to get up and walk or do other complex actions while asleep. Sleep-related eating disorder is a variant of SW in which people get up frequently to eat and drink while asleep.

Data and Resources

Additional Info

Field	Value
Last Updated	April 17, 2026, 17:42 (UTC)
Created	April 17, 2026, 17:42 (UTC)
criticality_level	[]
geographic_scope	[]
open_canada_collection	publication
open_canada_date_published	2017-09-21 00:00:00
open_canada_keywords	{"fr": ["Examen sommaire de l'innocuité", "antipsychotiques atypiques", "évaluation", "risque potentiel", "somnambulisme", "troubles de l'alimentation liés au sommeil", "ziprasidone", "se lever et marcher", "manger et boire pendant le sommeil"], "en": ["Summary Safety Review", "Atypical antipsychotics", "assessing", "potential risk", "sleep walking", "sleep-related eating disorder", "ziprasidone", "get-up and walk", "eat-and-drink while asleep"]}
open_canada_subject	["health_and_safety"]
sensitivity_level	unrestricted
title_fr	Résumé de l'examen de l'innocuité - Antipsychotiques atypiques - Évaluation du risque potentiel de somnambulisme et de trouble de l'alimentation lié au sommeil
update_frequency	as_needed